E. Jon Jacobsen

3.2k total citations
44 papers, 2.1k citations indexed

About

E. Jon Jacobsen is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, E. Jon Jacobsen has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Organic Chemistry, 21 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in E. Jon Jacobsen's work include Neuroscience and Neuropharmacology Research (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Chemical synthesis and alkaloids (7 papers). E. Jon Jacobsen is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Chemical synthesis and alkaloids (7 papers). E. Jon Jacobsen collaborates with scholars based in United States, United Kingdom and Switzerland. E. Jon Jacobsen's co-authors include J. Mark Braughler, Larry E. Overman, J. M. MCCALL, R L Chase, L A Duncan, Edward D. Hall, Kenneth L. Belonga, Eugene D. Means, John W. Mickelson and Michel Baudry and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

E. Jon Jacobsen

44 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Jon Jacobsen United States 23 779 644 226 221 215 44 2.1k
Fengtian Xue United States 27 595 0.8× 738 1.1× 104 0.5× 181 0.8× 163 0.8× 90 1.9k
Philip V. LoGrasso United States 38 900 1.2× 2.7k 4.2× 332 1.5× 458 2.1× 239 1.1× 79 4.0k
Sung‐Eun Yoo South Korea 22 592 0.8× 548 0.9× 148 0.7× 111 0.5× 59 0.3× 107 1.4k
Andrew D. White United States 18 666 0.9× 1.1k 1.8× 260 1.2× 174 0.8× 99 0.5× 37 2.0k
Joseph J. Lynch United States 38 637 0.8× 1.8k 2.7× 411 1.8× 189 0.9× 40 0.2× 165 4.3k
Rajesh Devraj United States 20 746 1.0× 951 1.5× 129 0.6× 218 1.0× 66 0.3× 35 1.9k
Kirk R. Maples United States 19 343 0.4× 507 0.8× 74 0.3× 80 0.4× 104 0.5× 33 1.5k
Shi‐Liang Huang China 37 942 1.2× 1.3k 2.1× 97 0.4× 263 1.2× 231 1.1× 116 3.2k
Puay‐Wah Phuan United States 28 469 0.6× 1.1k 1.6× 122 0.5× 82 0.4× 411 1.9× 52 2.4k
Erich L. Grimm Canada 19 471 0.6× 703 1.1× 220 1.0× 125 0.6× 133 0.6× 39 1.7k

Countries citing papers authored by E. Jon Jacobsen

Since Specialization
Citations

This map shows the geographic impact of E. Jon Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Jon Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Jon Jacobsen more than expected).

Fields of papers citing papers by E. Jon Jacobsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Jon Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Jon Jacobsen. The network helps show where E. Jon Jacobsen may publish in the future.

Co-authorship network of co-authors of E. Jon Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Jon Jacobsen. A scholar is included among the top collaborators of E. Jon Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Jon Jacobsen. E. Jon Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tavis, John E., Xiaohong Cheng, Yuan Hu, et al.. (2013). The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes. PLoS Pathogens. 9(1). e1003125–e1003125. 92 indexed citations
2.
Hughes, Robert, Todd M. Maddux, D. Joseph Rogier, et al.. (2011). Investigation of the pyrazinones as PDE5 inhibitors: Evaluation of regioisomeric projections into the solvent region. Bioorganic & Medicinal Chemistry Letters. 21(21). 6348–6352. 12 indexed citations
3.
Tollefson, Michael B., E. Jon Jacobsen, Robert Hughes, et al.. (2010). 1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(10). 3120–3124. 21 indexed citations
4.
Chrencik, Jill, Akshay Patny, Iris Leung, et al.. (2010). Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6. Journal of Molecular Biology. 400(3). 413–433. 173 indexed citations
5.
Tollefson, Michael B., E. Jon Jacobsen, Robert Hughes, et al.. (2010). 1-(2-(2,2,2-Trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(10). 3125–3128. 12 indexed citations
6.
Harris, Melissa S., Jeffrey H. Bock, Gil H. Choi, et al.. (2002). Co-crystallization ofStaphylococcus aureuspeptide deformylase (PDF) with potent inhibitors. Acta Crystallographica Section D Biological Crystallography. 58(12). 2153–2156. 3 indexed citations
7.
Stockman, Brian J., Daniel J. Waldon, Terrence A. Scahill, et al.. (1998). Solution structures of stromelysin complexed to thiadiazole inhibitors. Protein Science. 7(11). 2281–2286. 19 indexed citations
8.
Im, Haesook K., Wha Bin Im, Jeffrey F. Pregenzer, et al.. (1998). Two imidazoquinoxaline ligands for the benzodiazepine site sharing a second low affinity site on rat GABAA receptors but with the opposite functionality. British Journal of Pharmacology. 123(8). 1490–1494. 3 indexed citations
9.
Tang, A. H., et al.. (1997). Anxiolytic-like effects of PNU-101017, a partial agonist at the benzodiazepine receptor. Psychopharmacology. 131(3). 255–263. 10 indexed citations
10.
Im, Haesook K., et al.. (1996). Characterization of U-101017 as a GABAA receptor ligand of dual functionality. Brain Research. 714(1-2). 165–168. 14 indexed citations
12.
Im, Haesook K., et al.. (1995). Characterization of U‐97775 as a GABAA receptor ligand of dual functionality in cloned rat GABAA receptor subtypes. British Journal of Pharmacology. 115(1). 19–24. 7 indexed citations
13.
Mickelson, John W., Kenneth L. Belonga, & E. Jon Jacobsen. (1995). ChemInform Abstract: Asymmetric Synthesis of 2,6‐Methylated Piperazines.. ChemInform. 26(46). 1 indexed citations
14.
Richards, I M, Robert L. Griffin, S F Fidler, & E. Jon Jacobsen. (1993). Effect of the 21-aminosteroid, U-74389F, on hyperoxic lung injury in rats. Inflammation Research. 39(S1). 136–138. 7 indexed citations
15.
Baudry, Michel, et al.. (1993). Salen-Manganese Complexes Are Superoxide Dismutase-Mimics. Biochemical and Biophysical Research Communications. 192(2). 964–968. 187 indexed citations
16.
Im, Wha Bin, Haesook K. Im, Jeffrey F. Pregenzer, et al.. (1993). Differential affinity of dihydroimidazoquinoxalines and diimidazoquinazolines to the α1β2γ2 and α6β2γ2 subtypes of cloned GABAA receptors. British Journal of Pharmacology. 110(2). 677–680. 12 indexed citations
17.
Petke, James D., Haesook K. Im, Wha Bin Im, et al.. (1992). Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.. Molecular Pharmacology. 42(2). 294–301. 15 indexed citations
18.
Hall, Edward D., J. Mark Braughler, Patricia A. Yonkers, et al.. (1991). U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.. Journal of Pharmacology and Experimental Therapeutics. 258(2). 688–694. 131 indexed citations
19.
Jacobsen, E. Jon, John M. McCall, Donald E. Ayer, et al.. (1990). Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma. Journal of Medicinal Chemistry. 33(4). 1145–1151. 77 indexed citations
20.
Braughler, J. Mark, Philip S. Burton, R L Chase, et al.. (1988). Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochemical Pharmacology. 37(20). 3853–3860. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026